VALIRX PLC Logo

VALIRX PLC

Advancing oncology & women's health therapeutics and offering preclinical research services.

VAL | IL

Overview

Corporate Details

ISIN(s):
GB00BLH13C52
LEI:
213800VQKB9SJCQDET40
Country:
United Kingdom
Address:
STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ValiRx PLC is a life science company dedicated to the early-stage development of therapeutics, with a primary focus on oncology and women's health. The company accelerates the translation of scientific discoveries into clinical applications by providing scientific, financial, and commercial expertise to progress its portfolio of drug candidates. Through its subsidiary, Inaphaea BioLabs, ValiRx also offers a suite of preclinical research services. The company's core strategy is to identify and advance innovative treatments for diseases with unmet medical needs, aiming to improve patient lives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 08:00
Regulatory News Service
Inaphaea Commercial Update
English 23.6 KB
2025-08-26 08:00
Regulatory News Service
Commercial update
English 17.7 KB
2025-08-07 11:51
Regulatory News Service
ValiRx Awarded Grant from Open University
English 16.2 KB
2025-08-05 10:53
M&A Activity
Update on Evaluation Agreement with Stingray Bio
English 17.9 KB
2025-08-04 08:00
M&A Activity
Licensing Agreement with Dominion Biotech Ltd
English 16.3 KB
2025-07-29 08:00
M&A Activity
Collaboration Agreement with Voxcell BioInnovation
English 17.2 KB
2025-06-20 08:00
M&A Activity
Ambrose Exercise Option on VAL401
English 16.9 KB
2025-06-06 11:54
Major Shareholding Notification
Holding(s) in Company
English 54.3 KB
2025-06-06 08:00
Annual Report
Final Results & Notice of AGM
English 174.1 KB
2025-06-03 08:00
Regulatory News Service
New Evaluation and Material Transfer Agreement
English 15.3 KB
2025-03-27 08:00
Board/Management Information
Directorate Changes and new Advisory Board
English 20.7 KB
2025-02-24 08:00
Regulatory News Service
Conclusion of Evaluation Project
English 15.0 KB
2025-02-03 08:00
Regulatory News Service
Inaphaea Evaluation and Commercial Use Agreement
English 17.0 KB
2025-01-30 08:00
M&A Activity
Extension of Evaluation Agreement
English 15.0 KB
2025-01-29 08:00
M&A Activity
New Evaluation and Option Agreement
English 15.5 KB

Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for VALIRX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.